Pafuramidine (formulated as the maleic acid salt pafuramidine maleate) is an experimental drug for the treatment of pneumocystis pneumonia (PCP). In 2006 pafuramidine was given orphan drug status by the US Food and Drug Administration for PCP in patients with HIV/AIDS.
This page contains content from the copyrighted Wikipedia article "Pafuramidine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
